Presenting Companies Announced for 11th Annual BIO Investor Forum.
Share:
Press Release Summary:
BIO announced private and public companies that will be presenting at 11th Annual BIO Investor Forum, which will take place October 9-10, 2012 in San Francisco, CA. Companies were chosen via competitive screening process with input from BIO and event's advisory committee. With focus on venture-stage growth and emerging public companies as well as those poised to join growth watch list in 2013, international investor forum explores investment trends and opportunities in life sciences.
Original Press Release:
BIO Announces Presenting Companies for 11th Annual BIO Investor Forum
Investor Forum will be held October 9-10, 2012 in San Francisco, CA
2012:Biotechnology Industry Organization
WASHINGTON--The Biotechnology Industry Organization (BIO) announces the initial list of presenting companies for the 11th Annual BIO Investor Forum, an international investor forum which explores investment trends and opportunities in life sciences, with a focus on venture-stage growth and emerging public companies as well as those poised to join the growth "watch list" in 2013. The event will take place October 9-10, 2012 at the Palace Hotel in San Francisco, Calif.
"The aim of the BIO Investor Forum is to bring together a select group of private and early stage biotech companies along with leading investors in an effort to establish relationships and foster the development of new partnerships and, ultimately, new medicines. This year, we already have an exciting line-up of companies who will present their innovative products and technologies, from emerging public companies working on late-stage clinical trials, to newly-established Discovery companies developing novel biologics platforms," said Alan Eisenberg, executive vice president, Emerging Companies & Business Development at BIO.
Companies were chosen through a competitive screening process with input from BIO and the event's advisory committee. The committee is comprised of members from top-tier firms focused on investing and banking in the life sciences industry in addition to executives from emerging and leading biotech companies.
The following companies will present at the 11th Annual BIO Investor Forum:
Private:
Acetylon Pharmaceuticals
Affimed Therapeutics AG
AlloCure Inc.
Altheus Therapeutics
Ambit Biosciences
bluebird bio
Celtaxsys
Ceregene
Chimerix
Collegium Pharmaceutical
Colucid Pharmaceuticals
Contrafect Corporation
Cylene Pharmaceuticals
Dicerna Pharmaceuticals
Epizyme
FORMA Therapeutics
Galleon Pharmaceuticals
GlycoMimetics
Immune Design Corp.
Immune Targeting Systems Ltd.
Intarcia Therapeutics
Intrexon Corporation
KemPharm, Inc.
KineMed
Lipocine
MabVax Therapeutics
Metabolex
Metabolon
Midatech Group Ltd.
Neurotez
NexBio
NOXXON Pharma AG
Profil Institute for Translational Medicine
Promedior
Prosensa Therapeutics
ProtAffin Biotechnologie AG
Protagonist Therapeutics, Inc.
Proteostasis Therapeutics
Sage Therapeutics
Sutro Biopharma
Tetraphase Pharmaceuticals
TheraVida
TissueGene
Trellis Bioscience, LLC
Ultragenyx Pharmaceutical
Zafgen
Zosano Pharma
Public:
AcelRx Pharmaceuticals
Addex Therapeutics
Advaxis
ADVENTRX Pharmaceuticals
Allon Therapeutics
Aradigm Corporation
Astex Pharmaceuticals
Benitec Biopharma Ltd.
Bio-Path Holdings
BioSante Pharmaceuticals
Circadian Technologies Limited
Cyclacel Pharmaceuticals
Durata Therapeutics
Galena Biopharma
GenVec
Horizon Pharma
Immunovaccine
Karolinska Development AB
MEI Pharma
Resverlogix Corp.
Senesco Technologies
Sophiris Bio
Spectrum Pharmaceuticals
SymBio Pharmaceuticals Limited
Threshold Pharmaceuticals
Transgene SA
Tranzyme Pharma
ZIOPHARM Oncology
Now a staple at the Investor Forum, the event will once again feature a series of Discovery Track presentations. The presentations will focus on Seed and A-round companies incorporated after 2007 that have raised less than $25M total through October 2012. Companies in this track are also first-time presenters and use biotechnology or related technologies for research and development of drug products or diagnostics. The following companies are scheduled to present in the Private - Discovery Track:
Applied Microarrays
Arrogene
Déclion Pharmaceuticals
Eqalix
HeatFlow Technologies
Immunome
Immunomic
Inception Sciences
InnoBioscience
LoneStar Heart, Inc.
NTpharma LLC
Omniox
Regenesance BV
Retrophin LLC
Serina Therapeutics
Susavion Biosciences, Inc.
Tunitas Therapeutics
Wellesley Pharmaceuticals
Xalud Therapeutics
Check back often as new presenters are continuously being added. If you are interested in becoming a presenter, please submit an application here.
The BIO Investor Forum is a must attend event for public and private market investors, research analysts, investment bankers, and industry executives focused on investment and business development opportunities in the life sciences. BIO One-on-One Partnering(TM) will also provide an opportunity to arrange meetings between investors; companies; and industry business development, licensing and therapeutic franchise heads.
To learn more about the BIO Investor Forum, including registration and program information, please visit here. Registration is complimentary for credentialed members of the media and qualified investors.
BIO is pleased to recognize the leadership provided by the BIO Investor Forum Conference sponsors including Supporting Banks Stifel, Nicolaus & Company, and Roth Capital. BIO Double Helix and Helix Sponsors include Abbott Biotech Ventures, Amgen Ventures, Baxter Ventures, J&J Development Corporation, MedImmune Ventures, GlaxoSmithKline, Merck, and Pfizer.
About BIO
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces BIOtechNOW, an online portal and monthly newsletter chronicling "innovations transforming our world." Subscribe to BIOtechNOW.
